SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age group
Published
Covovax is the 4th Covid vaccine authorised for administration in 12 years and above after ZyCoV-D, Bharat Biotech's Covaxin, Biological E's Corbevax.
Full Article